Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

45.7K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.7K
Leaky Scanning02:28

Leaky Scanning

5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

5.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coaxial One-Dimensional Nanowires: Artificial Interface Engineering for Next-Generation Energy Storage.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Oridonin inhibits HIF-1α ubiquitination by targeting PHD2 in oligodendrocyte precursor cells to promote angiogenesis after ischemic stroke.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2026
Same author

Zincophilic Nanowire Array With Hydrophobic Iodine Elimination Layer for Ultrastable Zinc-Iodine Battery.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Translating Molecular Insights into Effective Targeting of Glioblastoma Stem Cells.

Cancers·2026
Same author

Rapid intraoperative cytokeratin immunohistochemistry improves diagnostic accuracy of sentinel lymph nodes in post-neoadjuvant breast cancer.

Virchows Archiv : an international journal of pathology·2026
Same author

Allospecific splenic Tr1 cells drive effector T cell exhaustion through up-regulated Areg-EGFR signaling to promote transplant tolerance.

Science advances·2026

Related Experiment Video

Updated: Jun 11, 2025

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

15.6K

Putting a Kink in HIV-1 Particle Infectivity: Rocaglamide Inhibits HIV-1 Replication by Altering Gag-Genomic RNA

Paul Rosenfeld1, Gatikrushna Singh2, Amanda Paz Herrera3

  • 1Institute of Medical Sciences, University of Toronto, Toronto, ON M5S 1A8, Canada.

Viruses
|September 28, 2024
PubMed
Summary

Rocaglamide (RocA) inhibits HIV-1 replication by disrupting Gag and genomic RNA assembly. This compound prevents the formation of infectious viral particles by altering eIF4A1 binding to viral RNA.

Keywords:
RNA structureeIF4A1guanosine-adenosine motifribonucleoprotein assembly

More Related Videos

Visualization of HIV-1 Gag Binding to Giant Unilamellar Vesicle GUV Membranes
08:21

Visualization of HIV-1 Gag Binding to Giant Unilamellar Vesicle GUV Membranes

Published on: July 28, 2016

8.9K
A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion
07:22

A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion

Published on: August 14, 2018

6.4K

Related Experiment Videos

Last Updated: Jun 11, 2025

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

15.6K
Visualization of HIV-1 Gag Binding to Giant Unilamellar Vesicle GUV Membranes
08:21

Visualization of HIV-1 Gag Binding to Giant Unilamellar Vesicle GUV Membranes

Published on: July 28, 2016

8.9K
A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion
07:22

A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion

Published on: August 14, 2018

6.4K

Area of Science:

  • Virology
  • Molecular Biology
  • Drug Discovery

Background:

  • RNA helicases play crucial roles in viral replication.
  • Rocaglamide (RocA) is a known modulator of eukaryotic initiation factor 4A1 (eIF4A1).

Purpose of the Study:

  • To investigate the role of RNA helicases in HIV-1 replication.
  • To identify inhibitors of HIV-1 replication targeting viral assembly.

Main Methods:

  • Cell-based assays in primary CD4+ T cells and other cell systems.
  • Viral particle formation and Gag production analysis.
  • Co-localization studies of Gag and HIV-1 genomic RNA (gRNA).
  • Ribonucleoprotein (RNP) immunoprecipitation.
  • Biophysical studies and electron microscopy of HIV-1 RNP structure.

Main Results:

  • RocA significantly inhibits HIV-1 replication at low nanomolar doses.
  • RocA treatment reduces viral particle formation without affecting Gag production.
  • Impaired co-localization of Gag and gRNA assemblies was observed.
  • RocA induces stable binding of eIF4A1 to the viral RNA genome.
  • Electron microscopy revealed distorted HIV-1 RNP structures.

Conclusions:

  • RocA acts as an inhibitor of HIV-1 replication.
  • The mechanism involves interference with Gag-gRNA assembly through altered eIF4A1 binding.
  • RocA represents a potential therapeutic agent for HIV-1 infection by targeting viral assembly.